EMD20001: A Prospective, Randomized, Placebo-Controlled, Dose Ranging Multi-Center Study of the Safety and Efficacy of 3 Days Continuous Intravenous Infusion of GR270773 in the Treatment of Suspected Confirmed Gram-negative Severe Sepsis in Adults